Harnessing innate mechanisms of gene activation, small activating RNA (RNAa) therapeutics are a revolutionary new class of medicines that can restore or boost normal function of genes in patients’ cells. We are advancing a proprietary pipeline of new medicines with an initial focus on genetic medicine, while collaborating with leading pharmaceutical companies to apply our technology platform across a broad range of other therapeutic areas.